53 results on '"Asthma surgery"'
Search Results
2. Procedural and short-term safety of bronchial thermoplasty in clinical practice: evidence from a national registry and Hospital Episode Statistics.
- Author
-
Burn J, Sims AJ, Keltie K, Patrick H, Welham SA, Heaney LG, and Niven RM
- Subjects
- Adult, Age Factors, Aged, Catheter Ablation adverse effects, Female, Humans, Length of Stay, Male, Middle Aged, Patient Readmission, Quality of Life, Respiratory Function Tests, Severity of Illness Index, State Medicine, United Kingdom, Asthma surgery, Catheter Ablation methods
- Abstract
Objective: Bronchial thermoplasty (BT) is a novel treatment for severe asthma. Its mode of action and ideal target patient group remain poorly defined, though clinical trials provided some evidence on efficacy and safety. This study presents procedural and short-term safety evidence from routine UK clinical practice., Methods: Patient characteristics and safety outcomes (procedural complications, 30-day readmission and accident and emergency (A&E) attendance, length of stay) were assessed using two independent data sources, the British Thoracic Society UK Difficult Asthma Registry (DAR) and Hospital Episodes Statistics (HES) database. A matched cohort (with records in both) was used to estimate safety outcome event rates and compare them with clinical trials., Results: Between June 2011 and January 2015, 215 procedure records (83 patients; 68 treated in England) were available from DAR and 203 (85 patients) from HES. 152 procedures matched (59 patients; 6 centres), and of these, 11.2% reported a procedural complication, 11.8% resulted in emergency respiratory readmission, 0.7% in respiratory A&E attendance within 30 days (20.4% had at least one event) and 46.1% involved a post-procedure stay. Compared with published clinical trials which found lower hospitalisation rates, BT patients in routine clinical practice were, on average, older, had worse baseline lung function and asthma quality of life., Conclusions: A higher proportion of patients experienced adverse events compared with clinical trials. The greater severity of disease amongst patients treated in clinical practice may explain the observed rate of post-procedural stay and readmission. Study of long-term safety and efficacy requires continuing data collection.
- Published
- 2017
- Full Text
- View/download PDF
3. Bronchial Thermoplasty: Misleading Differences in Asthma Exacerbation Rates!
- Author
-
Ibrahim W
- Subjects
- Humans, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Muscle, Smooth surgery, Plastic Surgery Procedures methods
- Published
- 2016
- Full Text
- View/download PDF
4. Bronchial thermoplasty: a review of the evidence.
- Author
-
Wilhelm CP and Chipps BE
- Subjects
- Animals, Humans, Asthma surgery, Bronchoscopy methods, Catheter Ablation methods
- Published
- 2016
- Full Text
- View/download PDF
5. Effectiveness of bronchial thermoplasty in severe asthma in 'real life' patients compared with those recruited to clinical trials in the same centre.
- Author
-
Bicknell S, Chaudhuri R, Lee N, Shepherd M, Spears M, Pitman N, Cameron E, Cowan D, Nixon J, Thompson J, McSharry C, and Thomson NC
- Subjects
- Adult, Anti-Asthmatic Agents therapeutic use, Asthma diagnosis, Asthma physiopathology, Bronchi physiopathology, Bronchoscopy adverse effects, Catheter Ablation adverse effects, Female, Forced Expiratory Volume, Humans, Male, Middle Aged, Recovery of Function, Scotland, Severity of Illness Index, Time Factors, Treatment Outcome, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Clinical Trials as Topic methods, Patient Selection
- Abstract
Published information on the effectiveness of bronchial thermoplasty (BT) for severe asthma in 'real life' patients is limited. We compared safety and efficacy outcomes 12 months post procedure in 10 clinic patients and 15 patients recruited to clinical trials of BT at the same centre. Baseline asthma severity was greater in the clinic group. Adverse events were similar. Clinical improvements occurred in 50% of the clinic patients compared with 73% of the research patients., (© The Author(s), 2015.)
- Published
- 2015
- Full Text
- View/download PDF
6. Effects of Bronchial Thermoplasty on Airway Smooth Muscle and Collagen Deposition in Asthma.
- Author
-
Chakir J, Haj-Salem I, Gras D, Joubert P, Beaudoin ÈL, Biardel S, Lampron N, Martel S, Chanez P, Boulet LP, and Laviolette M
- Subjects
- Adrenal Cortex Hormones therapeutic use, Adult, Asthma drug therapy, Asthma pathology, Biopsy, Bronchoscopy methods, Collagen Type I, Female, Follow-Up Studies, Humans, Male, Middle Aged, Treatment Outcome, Airway Remodeling, Asthma surgery, Bronchi surgery, Catheter Ablation methods, Muscle, Smooth pathology
- Abstract
Rationale: The aim of bronchial thermoplasty is to improve asthma symptoms by reducing central airway smooth muscle mass. Up to now, the reduction of smooth muscle mass has been documented for only 1 group of 10 patients who had 15% or more of their pretreatment total bronchial biopsy area occupied by smooth muscle., Objectives: To evaluate the effects of bronchial thermoplasty on airway smooth muscle mass and airway collagen deposition in adult patients with asthma, regardless of pretreatment smooth muscle area., Methods: Seventeen patients with asthma underwent bronchial thermoplasty over the course of three visits. At Visit 1, bronchial biopsies were taken from the lower lobe that was not treated during this session. At Visit 2 (3-14 wk after the first visit), all 17 patients underwent biopsy of the lower lobe treated during the first procedure. At Visit 3 (7-22 wk after the first visit), nine patients agreed to undergo biopsy of the same lower lobe. Histological and immunohistochemical analyses were performed on the biopsy specimens., Measurements and Main Results: Bronchial thermoplasty decreased airway smooth muscle from 12.9 ± 1.2% of the total biopsy surface at Visit 1 to 4.6 ± 0.8% at Visit 2 (P < 0.0001). For the nine patients who underwent a third biopsy, mean airway smooth muscle area was 5.3 ± 1.3% at Visit 3 (P = 0.0008 compared with baseline). Bronchial thermoplasty also decreased Type I collagen deposition underneath the basement membrane from 6.8 ± 0.3 μm at Visit 1 to 4.3 ± 0.2 μm at Visit 2 (P < 0.0001) and to 4.4 ± 0.4 μm for nine patients at Visit 3 (P < 0.0001 compared with baseline). Over the course of 1 year after treatment, the doses of inhaled corticosteroid, the number of severe exacerbations, and asthma control all improved (P ≤ 0.02)., Conclusions: For patients with severe asthma, bronchial thermoplasty reduced the smooth muscle mass of treated airway segments, regardless of the baseline level of muscle mass. Treatment also altered the deposition of collagen. At follow-up, bronchial thermoplasty improved asthma control; however, the limited number of subjects did not allow us to evaluate possible correlations between these improvements and the studied histological parameters. Further studies are needed to confirm these results and evaluate their persistence.
- Published
- 2015
- Full Text
- View/download PDF
7. Indications for the use of bronchial thermoplasty in severe asthma.
- Author
-
Dheda K, Koegelenberg CF, Esmail A, Irusen E, Wechsler ME, Niven RM, Chung KF, and Bateman ED
- Subjects
- Humans, Patient Selection, South Africa, Asthma surgery, Bronchoscopy, Catheter Ablation
- Abstract
Approximately 5% of the ~3 million asthmatics in South Africa have severe asthma that is associated with substantial morbidity, cost, absenteeism, preventable mortality, and the requirement for costly chronic medication that may be associated with significant adverse events. There is an unmet need for alternative safer and more effective interventions for severe asthma. A recently introduced option, bronchial thermoplasty (BT), imparts radiofrequency-generated heat energy to the airways to cause regression of airway smooth muscle. The effectiveness of this technique has been confirmed in randomised control trials and is now endorsed by several international guidelines, including the Global Initiative for Asthma (GINA) guideline, the British Asthma Guideline, and the UK National Institute of Clinical Excellence (NICE) guideline. We recommend BT as a potential therapeutic intervention for severe uncontrolled asthma, provided that it is performed by an experienced pulmonologist at an accredited centre and done within the broader context of appropriate management of the disease by doctors experienced in treating difficult-to-control asthma.
- Published
- 2015
- Full Text
- View/download PDF
8. Airway Inflammation after Bronchial Thermoplasty for Severe Asthma.
- Author
-
Denner DR, Doeing DC, Hogarth DK, Dugan K, Naureckas ET, and White SR
- Subjects
- Adult, Asthma drug therapy, Biopsy, Bronchi pathology, Bronchoalveolar Lavage Fluid cytology, Bronchoscopy, Cytokines analysis, Female, Humans, Male, Muscle, Smooth pathology, Prospective Studies, Severity of Illness Index, Anti-Inflammatory Agents administration & dosage, Asthma surgery, Catheter Ablation methods, Inflammation drug therapy, Postoperative Complications pathology, Prednisone administration & dosage
- Abstract
Rationale: Bronchial thermoplasty is an alternative treatment for patients with severe, uncontrolled asthma in which the airway smooth muscle is eliminated using radioablation. Although this emerging therapy shows promising outcomes, little is known about its effects on airway inflammation., Objectives: We examined the presence of bronchoalveolar lavage cytokines and expression of smooth muscle actin in patients with severe asthma before and in the weeks after bronchial thermoplasty., Methods: Endobronchial biopsies and bronchoalveolar lavage samples from 11 patients with severe asthma were collected from the right lower lobe before and 3 and 6 weeks after initial bronchial thermoplasty. Samples were analyzed for cell proportions and cytokine concentrations in bronchoalveolar lavage and for the presence of α-SMA in endobronchial biopsies., Measurements and Main Results: α-SMA expression was decreased in endobronchial biopsies of 7 of 11 subjects by Week 6. In bronchoalveolar lavage fluid, both transforming growth factor-β1 and regulated upon activation, normal T-cell expressed and secreted (RANTES)/CCL5 were substantially decreased 3 and 6 weeks post bronchial thermoplasty in all patients. The cytokine tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL), which induces apoptosis in several cell types, was increased in concentration both 3 and 6 weeks post bronchial thermoplasty., Conclusions: Clinical improvement and reduction in α-SMA after bronchial thermoplasty in severe, uncontrolled asthma is associated with substantial changes in key mediators of inflammation. These data confirm the substantial elimination of airway smooth muscle post thermoplasty in the human asthmatic airway and represent the first characterization of significant changes in airway inflammation in the first weeks after thermoplasty.
- Published
- 2015
- Full Text
- View/download PDF
9. Bronchial thermoplasty in asthma: 2-year follow-up using optical coherence tomography.
- Author
-
Kirby M, Ohtani K, Lopez Lisbona RM, Lee AM, Zhang W, Lane P, Varfolomeva N, Hui L, Ionescu D, Coxson HO, MacAulay C, FitzGerald JM, and Lam S
- Subjects
- Asthma diagnostic imaging, Asthma pathology, Biopsy, Needle, Bronchoscopy methods, Female, Humans, Immunohistochemistry, Male, Middle Aged, Pilot Projects, Postoperative Care methods, Prognosis, Radiography, Risk Assessment, Sampling Studies, Severity of Illness Index, Treatment Outcome, Airway Remodeling physiology, Asthma surgery, Catheter Ablation methods, Tomography, Optical Coherence methods
- Published
- 2015
- Full Text
- View/download PDF
10. Reply: reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma.
- Author
-
Aubier M, Pretolani M, Chanez P, Thabut G, Debray MP, Taille C, Knap D, and Hamidi F
- Subjects
- Female, Humans, Male, Asthma surgery, Bronchi surgery, Catheter Ablation methods, Muscle, Smooth surgery
- Published
- 2015
- Full Text
- View/download PDF
11. Reduction of airway smooth muscle mass after bronchial thermoplasty: are we there yet?
- Author
-
Bonta PI, d'Hooghe J, Sterk PJ, Bel EH, and Annema JT
- Subjects
- Female, Humans, Male, Asthma surgery, Bronchi surgery, Catheter Ablation methods, Muscle, Smooth surgery
- Published
- 2015
- Full Text
- View/download PDF
12. Response.
- Author
-
Iyer VN and Lim KG
- Subjects
- Humans, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Muscle, Smooth surgery, Plastic Surgery Procedures methods
- Published
- 2015
- Full Text
- View/download PDF
13. Response.
- Author
-
Irwin RS
- Subjects
- Humans, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Muscle, Smooth surgery, Plastic Surgery Procedures methods
- Published
- 2015
- Full Text
- View/download PDF
14. Bronchial thermoplasty: ready for prime time--the evidence is there!
- Author
-
Castro M, Cox G, Wechsler ME, and Niven RM
- Subjects
- Humans, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Muscle, Smooth surgery, Plastic Surgery Procedures methods
- Published
- 2015
- Full Text
- View/download PDF
15. Regional ventilation changes in severe asthma after bronchial thermoplasty with (3)He MR imaging and CT.
- Author
-
Thomen RP, Sheshadri A, Quirk JD, Kozlowski J, Ellison HD, Szczesniak RD, Castro M, and Woods JC
- Subjects
- Adult, Asthma diagnostic imaging, Female, Helium, Humans, Male, Middle Aged, Respiratory Function Tests, Treatment Outcome, Asthma physiopathology, Asthma surgery, Catheter Ablation methods, Magnetic Resonance Imaging methods, Tomography, X-Ray Computed methods
- Abstract
Purpose: To quantify regional lung ventilation in healthy volunteers and patients with severe asthma (both before and after thermoplasty) by using a combination of helium 3 ((3)He) magnetic resonance (MR) imaging and computed tomography (CT), with the intention of developing more effective image-guided treatments for obstructive lung diseases., Materials and Methods: With approval of the local institutional review board, informed consent, and an Investigational New Drug Exemption, six healthy volunteers and 10 patients with severe asthma were imaged in compliance with HIPAA regulations by using both multidetector CT and (3)He MR imaging. Individual bronchopulmonary segments were labeled voxel by voxel from the CT images and then registered to the (3)He MR images by using custom software. The (3)He signal intensity was then analyzed by evaluating the volume-weighted fraction of total-lung signal intensity present in each segment (segmental ventilation percentage [ SVP segmental ventilation percentage ]) and by identifying the whole-lung defect percentage and the segmental defect percentage. Of the 10 patients with asthma, seven received treatment with bronchial thermoplasty and were imaged with (3)He MR a second time. Changes in segmental defect percentages and whole-lung defect percentages are presented., Results: Ventilation measures for healthy volunteers yielded smaller segment-to-segment variation (mean SVP segmental ventilation percentage , 100% ± 18 [standard deviation]) than did the measures for patients with severe asthma (mean SVP segmental ventilation percentage , 97% ± 23). Patients with asthma also demonstrated larger segmental defect percentages (median, 13.5%; interquartile range, 8.9%-17.8%) than healthy volunteers (median, 6%; interquartile range, 5.6%-6.3%). These quantitative results confirm what is visually observed on the (3)He images. A Spearman correlation of r = -0.82 was found between the change in whole-lung defect percentage and the number of days between final treatment and second (3)He imaging., Conclusion: Regional quantification of lung ventilation is indeed feasible and may be a useful technique for image-guided treatment of obstructive lung diseases, such as bronchial thermoplasty for severe asthma. In these patients, ventilation defects decreased as a function of time after treatment.
- Published
- 2015
- Full Text
- View/download PDF
16. Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma.
- Author
-
Pretolani M, Dombret MC, Thabut G, Knap D, Hamidi F, Debray MP, Taille C, Chanez P, and Aubier M
- Subjects
- Female, Humans, Male, Treatment Outcome, Asthma surgery, Bronchi surgery, Catheter Ablation methods, Muscle, Smooth surgery
- Published
- 2014
- Full Text
- View/download PDF
17. Critical review of bronchial thermoplasty: where should it fit into asthma therapy?
- Author
-
Sheshadri A, McKenzie M, and Castro M
- Subjects
- Bronchoconstriction, Bronchoscopy, Humans, Quality of Life, Asthma surgery, Bronchi surgery, Catheter Ablation, Muscle, Smooth surgery
- Abstract
Bronchial thermoplasty is a device-based therapy for treatment of severe refractory asthma that uses radiofrequency energy to reduce airway smooth muscle and decrease bronchoconstriction. BT improves quality of life and decreases the rate of severe exacerbations with no known major long-term complications. The effectiveness of bronchial thermoplasty persists at least 5 years after the treatment is completed. Further investigation is needed to better define the specific subpopulation of patients with severe asthma who would best benefit from this treatment.
- Published
- 2014
- Full Text
- View/download PDF
18. Bronchial thermoplasty: reappraising the evidence (or lack thereof).
- Author
-
Iyer VN and Lim KG
- Subjects
- Humans, Treatment Outcome, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Muscle, Smooth surgery, Plastic Surgery Procedures methods
- Abstract
Bronchial thermoplasty (BT) involves the application of radiofrequency energy to visible proximal airways to selectively ablate airway smooth muscle. BT is the first nonpharmacologic interventional therapy approved by the US Food and Drug Administration (FDA) for severe asthma. This approval was based on the results of the pivotal Asthma Intervention Research (AIR)-2 trial, which is the only randomized, double-blind, sham-controlled trial of BT. The primary end point of the AIR-2 trial was improvement in the Asthma Quality of Life Questionnaire (AQLQ). The results of the AIR-2 trial have generated enormous interest, controversy, and confusion regarding the true efficacy of BT for severe asthma. Current marketing of BT highlights its use for patients with "severe" asthma, which is interpreted by most practicing clinicians as meaning oral corticosteroid dependence, frequent exacerbations, or a significantly reduced FEV1 with a poor quality of life. Did the AIR-2 trial include patients with a low FEV1, oral steroid dependence, or frequent exacerbations? Did the trial show efficacy for any of the primary or secondary end points? The FDA approved the device based on the reduction in severe asthma exacerbations. However, were the rates of asthma exacerbations, ED visits, or hospitalizations truly different between the two groups, and was this type of analysis even justified given the original study design? This commentary is designed to specifically answer these questions and help the practicing clinician navigate the thermoplasty literature with confidence and clarity. We carefully dissect the design, conduct, and results of the AIR-2 trial and raise serious questions about the efficacy of bronchial thermoplasty.
- Published
- 2014
- Full Text
- View/download PDF
19. Bronchial thermoplasty.
- Author
-
Kynyk J, Benninger C, and Wood KL
- Subjects
- Asthma diagnosis, Female, Follow-Up Studies, Humans, Male, Patient Selection, Risk Assessment, Severity of Illness Index, Treatment Outcome, Asthma surgery, Bronchoscopy methods, Catheter Ablation methods, Hot Temperature therapeutic use
- Abstract
Bronchial thermoplasty is a relatively new therapy for the management of severe asthma. It involves the direct bronchoscopic application of thermal energy to airways by a catheter-directed expandable basket. The airways of the lower and upper lobes are treated in 3 separate sessions spaced 3 weeks apart. The therapy targets airway smooth muscle, with studies showing a decrease in airway smooth muscle after bronchial thermoplasty therapy. After therapy, an improvement in quality of life and decrease in asthma exacerbations can be expected. Adverse events can occur with bronchial thermoplasty and careful patient selection is critical to ensure benefits outweigh the potential risks., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
20. Bronchial thermoplasty: a novel therapy for severe asthma.
- Author
-
Sheshadri A, Castro M, and Chen A
- Subjects
- Adult, Bronchoscopy methods, Catheter Ablation instrumentation, Contraindications, Humans, Asthma surgery, Bronchi surgery, Catheter Ablation methods
- Abstract
This article presents an overview of bronchial thermoplasty, a novel treatment for severe asthma. Within, the authors discuss the rationale for bronchial thermoplasty in severe asthma, current clinical evidence for the use of this procedure, clinical recommendations, and future directions., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
21. Payer coverage for bronchial thermoplasty: shifting the traditional paradigm for refractory asthma therapy.
- Author
-
Mahajan AK and Hogarth DK
- Subjects
- Humans, United States, Asthma economics, Asthma surgery, Catheter Ablation economics, Insurance Coverage economics, Medicare economics
- Abstract
The advent of bronchial thermoplasty (BT) provides a novel therapeutic option for asthma refractory to traditional medical therapy. Insurance coverage poses significant frustration for centers performing BT. Although clinical research has provided evidence of the usefulness and long-term safety of BT, establishing "reasonability and necessity" remains a daunting challenge in securing private and governmental insurance coverage. As a result, obtaining coverage poses significant frustration for centers capable of performing BT for patients suffering from severe asthma. Until recently, BT had been categorized by a temporary set of Current Procedural Terminology (CPT) codes as an emerging technology, service, or procedure (category 3). Based on increasing implementation of BT nationwide, the American Medical Association CPT Editorial Panel has assigned category 1 CPT codes for BT in their published 2013 professional edition. It is hoped that such a recommendation will reinforce the medical community's belief in the usefulness of BT and help facilitate decisions on insurance coverage. The ability to secure coverage for BT through physician advocacy and Centers for Medicare and Medicaid Services support will help move the treatment of refractory asthma forward.
- Published
- 2013
- Full Text
- View/download PDF
22. Bronchial thermoplasty failure in severe persistent asthma: a case report.
- Author
-
Doeing DC, Husain AN, Naureckas ET, White SR, and Hogarth DK
- Subjects
- Bronchoscopy methods, Female, Humans, Middle Aged, Treatment Failure, Asthma surgery, Bronchi surgery, Catheter Ablation methods
- Abstract
Introduction: Bronchial thermoplasty (BT) is an emerging therapy for patients with severe persistent asthma who remain poorly controlled despite standard maximal medical therapy. Thermoplasty elicits asthma control over time by applying thermal radiofrequency energy to airways to ablate underlying smooth muscle. While this therapy is suggested to eliminate such smooth muscle permanently, no human studies have examined the possibility of treatment failure., Case Report: We present a 62-year-old female with severe, refractory asthma symptoms who underwent BT without apparent complications. However, severe symptoms including multiple clinical exacerbations persisted despite BT treatment. Repeat endobronchial biopsy done six months after BT treatment demonstrated persistent smooth muscle hyperplasia in multiple airways that previously had been treated. The patient continued to have uncontrolled, refractory asthma despite multiple therapies., Conclusion: This case is the first to describe a failure of BT to reduce or eliminate airway smooth muscle in a patient with severe persistent asthma. It suggests the potential for treatment failure in the management of these patients after BT and highlights the need for further study of potential BT-refractory patients.
- Published
- 2013
- Full Text
- View/download PDF
23. Bronchial thermoplasty: a new treatment paradigm for severe persistent asthma.
- Author
-
Cayetano KS, Chan AL, Albertson TE, and Yoneda KY
- Subjects
- Asthma physiopathology, Humans, Muscle, Smooth surgery, Quality of Life, Randomized Controlled Trials as Topic, Treatment Outcome, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Severity of Illness Index
- Abstract
Patients with severe asthma represent only a minority of the total asthma population; however, they account for the majority of the mortality, morbidity, and health care-related cost of this chronic illness. Bronchial thermoplasty is a novel treatment modality that employs radiofrequency energy to alter the smooth muscles of the airways. This therapy represents a radical change in our treatment paradigm from daily repetitive dosing of medications to a truly long-term and potentially permanent attenuation of perhaps the most feared component of asthma--smooth muscle-induced bronchospasm. A large, multicentered, double-blinded, randomized controlled trial employed the unprecedented (but now industry standard for bronchoscopic studies) approach of using sham bronchoscopy as a control. It demonstrated that bronchial thermoplasty is safe, improved quality of life, and decreased frequency of severe exacerbations in the treatment group compared to the control group. Although the mechanism of action of bronchial thermoplasty is not currently completely understood, it should be considered as a valid and potentially valuable option for patients who have severe persistent asthma and who remain symptomatic despite inhaled corticosteroids and long-acting beta-2 agonists. Such patients should however be carefully evaluated at centers with expertise in managing severe asthma patients and with physicians who have experience with this promising new treatment modality.
- Published
- 2012
- Full Text
- View/download PDF
24. Bronchial thermoplasty: therapeutic success in severe asthma associated with persistent airflow obstruction.
- Author
-
Mahajan AK and Hogarth DK
- Subjects
- Adult, Asthma psychology, Catheter Ablation standards, Female, Humans, Quality of Life, Spirometry, Asthma surgery, Catheter Ablation methods
- Abstract
Introduction: Severe persistent asthma is a disabling condition associated with significant morbidity and rising mortality worldwide. The recent advent of bronchial thermoplasty (BT) has offered a revolutionary therapeutic option for the treatment of severe persistent asthma. This minimally invasive bronchoscopic procedure focuses on anatomical manipulation of bronchial smooth muscle to attenuate airway hyperresponsiveness., Case Report: This case report describes treatment of a 42-year-old female with BT for her debilitating asthma. Following a complicated treatment course of BT, she attained significant relief from her symptoms and had noticeably improved functionality., Conclusion: This case represents BT success and a change to the traditional paradigm governing the treatment of refractory asthma.
- Published
- 2012
- Full Text
- View/download PDF
25. Bronchial thermoplasty for severe asthma.
- Author
-
Thomson NC, Bicknell S, and Chaudhuri R
- Subjects
- Asthma physiopathology, Bronchi surgery, Bronchoscopy adverse effects, Catheter Ablation adverse effects, Humans, Quality of Life, Randomized Controlled Trials as Topic, Severity of Illness Index, Treatment Outcome, Asthma surgery, Bronchoscopy methods, Catheter Ablation methods
- Abstract
Purpose of Review: Bronchial thermoplasty, which involves the delivery of radio frequency energy to the airways to reduce airway smooth muscle mass, has been recently introduced for the treatment of severe asthma. This review summarizes the preclinical development, efficacy and adverse effects of bronchial thermoplasty. In addition, the potential mechanisms of action and place in management of severe asthma are discussed., Recent Findings: The efficacy and adverse profile of bronchial thermoplasty has been assessed in three randomized controlled trials, the first two of which showed clinical benefits of bronchial thermoplasty compared with usual care in patients with moderate or severe asthma. The third trial reports the results of a comparison with sham bronchial thermoplasty in 288 adults with severe asthma. Bronchial thermoplasty improved asthma quality of life questionnaire scores compared with sham bronchial thermoplasty; in the posttreatment period, there were fewer severe exacerbations and emergency department visits. Bronchial thermoplasty causes short-term increases in asthma-related morbidity. Follow-up data to date support the long-term safety of the procedure., Summary: Bronchial thermoplasty has a role in the management of patients with severe asthma who have uncontrolled symptoms despite current therapies. Future studies need to identify factors that predict a beneficial clinical response.
- Published
- 2012
- Full Text
- View/download PDF
26. Is there a role for bronchial thermoplasty in the treatment of asthma?
- Author
-
Boulet LP and Laviolette M
- Subjects
- Humans, Treatment Outcome, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Muscle, Smooth surgery
- Abstract
Bronchial thermoplasty is a new technique proposed to improve control of moderate to severe asthma. It delivers thermal energy to the large airways during a bronchoscopy to decrease the amount of bronchial smooth muscle. This intervention has been shown to reduce asthma exacerbations, and improve asthma control and quality of life over a three-year period without significant complications up to a five-year period. It could be considered as another option in the treatment of selected patients requiring oral and⁄or high doses of inhaled corticosteroids to control asthma. It should, however, be performed in specialized centres in patients who understand the potential benefits and side-effects of this technique. The response to this treatment varies from one patient to another. Consequently, further studies are required to better define the role of this option in the treatment of asthma.
- Published
- 2012
- Full Text
- View/download PDF
27. Bronchial thermoplasty for severe asthma.
- Author
-
Wahidi MM and Kraft M
- Subjects
- Bronchi surgery, Bronchoscopy adverse effects, Catheter Ablation adverse effects, Catheter Ablation instrumentation, Humans, Muscle, Smooth surgery, Treatment Outcome, Asthma surgery, Bronchoscopy methods, Catheter Ablation methods
- Abstract
Bronchial thermoplasty (BT) is a novel treatment of patients with severe asthma who continue to be symptomatic despite maximal medical treatment. It aims to reduce the smooth muscle mass in the airways by delivering controlled thermal energy to the airway walls during a series of three bronchoscopies. Randomized controlled clinical trials of BT in severe asthma have not been able to show a reduction in airway hyperresponsiveness or change in FEV(1) but have suggested an improvement in quality of life, as well as a reduction in the rate of severe exacerbations, emergency department visits, and days lost from school or work. Strict inclusion and exclusion criteria of these trials resulted in the elimination of patients with severe asthma who experienced more than three exacerbations per year. Therefore, the generalizability of this treatment to the broader severe asthma population still needs to be determined. The short-term adverse events consist primarily of airway inflammation and occasionally more severe events requiring hospitalization. Long-term safety data are evolving and have shown thus far clinical and functional stability up to 5 years after BT treatment. Additional studies on BT are needed to establish accurate phenotyping of positive responders, durability of effect, and long-term safety.
- Published
- 2012
- Full Text
- View/download PDF
28. Long-term safety data support use of bronchial thermoplasty.
- Author
-
Morrow T
- Subjects
- Asthma economics, Bronchoscopy economics, Catheter Ablation economics, Clinical Trials as Topic, Follow-Up Studies, Humans, Treatment Outcome, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods, Patient Safety
- Published
- 2011
29. Bronchial thermoplasty: a novel treatment for severe asthma requiring monitored anesthesia care.
- Author
-
Lee JA, Rowen DW, and Rose DD
- Subjects
- Adult, Female, Humans, Adjuvants, Anesthesia administration & dosage, Adrenergic alpha-2 Receptor Agonists administration & dosage, Anesthesia methods, Asthma surgery, Bronchoscopy, Catheter Ablation, Dexmedetomidine administration & dosage
- Abstract
Dexmedetomidine used in monitored anesthesia care produces a safe and effective technique well documented in research. We report the successful use of dexmedetomidine for sedation during bronchial thermoplasty, a new treatment for patients with severe persistent asthma refractory to inhaled corticosteroids and long-term beta-2 agonists.
- Published
- 2011
30. Bronchial thermoplasty: a promising therapy, still in its infancy.
- Author
-
Mahajan AK and Hogarth DK
- Subjects
- Humans, Asthma surgery, Bronchi, Bronchoscopy, Catheter Ablation instrumentation, Treatment Failure
- Published
- 2011
- Full Text
- View/download PDF
31. Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma.
- Author
-
Castro M, Rubin A, Laviolette M, Hanania NA, Armstrong B, and Cox G
- Subjects
- Adolescent, Adrenal Cortex Hormones therapeutic use, Adrenergic beta-2 Receptor Agonists therapeutic use, Adult, Aged, Anti-Asthmatic Agents therapeutic use, Asthma drug therapy, Bronchi drug effects, Bronchoscopy instrumentation, Catheter Ablation adverse effects, Chronic Disease, Disease Progression, Hospitalization, Humans, Middle Aged, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Respiratory Function Tests, Severity of Illness Index, Treatment Outcome, Young Adult, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation statistics & numerical data
- Abstract
Background: Bronchial thermoplasty (BT) has been demonstrated to be safe and effective in the treatment of severe persistent asthma out to at least 1 year. Preclinical studies have demonstrated that the reduction in airway smooth muscle after bronchial thermoplasty persists out to at least 3 years., Objectives: To examine the persistence of effectiveness of BT 2 years posttreatment in subjects with severe asthma., Methods: Subjects participating in the long-term safety follow-up phase of the Asthma Intervention Research 2 (AIR2) Trial were evaluated by comparing the proportion of subjects who experienced exacerbations, adverse events, or healthcare utilization during the first year (year 1) after BT treatment with the proportion of subjects who experienced the same during the subsequent 12 months (year 2)., Results: Severe exacerbations, respiratory adverse events, emergency department visits for respiratory symptoms, and hospitalizations for respiratory symptoms (proportion of subjects experiencing and rates of events), and stability of pre- and post-bronchodilator forced expiratory volume in 1 second (FEV(1)), were comparable between years 1 and 2. The proportion of subjects experiencing severe exacerbations in year 2 after BT was 23.0%, compared with 30.9% in year 1., Conclusions: The reduction in the proportion of subjects experiencing severe exacerbations after BT is maintained for at least 2 years. Bronchial thermoplasty provides beneficial long-term effects on asthma outcomes in patients with severe asthma., Trial Registration: clinicaltrials.gov, Identifier: NCT00231114., (Copyright © 2011 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
32. Bronchial thermoplasty: a new treatment for severe refractory asthma.
- Author
-
Gildea TR, Khatri SB, and Castro M
- Subjects
- Adrenal Cortex Hormones therapeutic use, Asthma drug therapy, Clinical Protocols, Forced Expiratory Volume, Humans, Muscle, Smooth, Severity of Illness Index, Asthma surgery, Bronchi, Bronchoscopy, Catheter Ablation instrumentation, Treatment Failure
- Abstract
Bronchial thermoplasty was recently approved for treating severe refractory asthma that is not well controlled by high-dose inhaled corticosteroids and long-acting bronchodilator therapy. This article reviews its indications, evidence of efficacy, and protocols.
- Published
- 2011
- Full Text
- View/download PDF
33. Bronchial thermoplasty for severe asthma.
- Author
-
Cox G
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Risk Assessment, Treatment Outcome, Asthma surgery, Bronchoscopy methods, Catheter Ablation methods, Severity of Illness Index
- Abstract
Purpose of Review: the present article will address the potential for bronchial thermoplasty to be used in addition to conventional medications to help us treat our patients with severe asthma., Recent Findings: two recently published studies report on the use of bronchial thermoplasty in patients with severe asthma. Now that patients with a range of asthma severity have been treated with bronchial thermoplasty, we are better able to comment on the appropriate selection of patients for this therapy that should optimize benefits and limit complications. In addition, studies reporting longer term follow-up are now available indicating the persistence of benefit and the absence of late developing adverse events., Summary: bronchial thermoplasty represents a novel approach to asthma treatment that is complementary to anti-inflammatory and bronchodilating therapies. Criteria for selecting appropriate patients are established and experience with bronchial thermoplasty is expanding since US Food and Drug Administration approval was obtained in April 2010.
- Published
- 2011
- Full Text
- View/download PDF
34. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma.
- Author
-
Gupta SS
- Subjects
- Asthma diagnosis, Humans, Severity of Illness Index, Treatment Outcome, Asthma surgery, Bronchi surgery, Catheter Ablation methods
- Published
- 2010
- Full Text
- View/download PDF
35. Bronchial thermoplasty: a novel therapeutic approach to severe asthma.
- Author
-
Duhamel DR and Hales JB
- Subjects
- Adult, Bronchoscopy methods, Humans, Asthma surgery, Bronchi surgery, Catheter Ablation methods
- Abstract
Bronchial thermoplasty is a non-drug procedure for severe persistent asthma that delivers thermal energy to the airway wall in a precisely controlled manner to reduce excessive airway smooth muscle. Reducing airway smooth muscle decreases the ability of the airways to constrict, thereby reducing the frequency of asthma attacks. Bronchial thermoplasty is delivered by the Alair System and is performed in three outpatient procedure visits, each scheduled approximately three weeks apart. The first procedure treats the airways of the right lower lobe, the second treats the airways of the left lower lobe and the third and final procedure treats the airways in both upper lobes. After all three procedures are performed the bronchial thermoplasty treatment is complete. Bronchial thermoplasty is performed during bronchoscopy with the patient under moderate sedation. All accessible airways distal to the mainstem bronchi between 3 and 10 mm in diameter, with the exception of the right middle lobe, are treated under bronchoscopic visualization. Contiguous and non-overlapping activations of the device are used, moving from distal to proximal along the length of the airway, and systematically from airway to airway as described previously. Although conceptually straightforward, the actual execution of bronchial thermoplasty is quite intricate and procedural duration for the treatment of a single lobe is often substantially longer than encountered during routine bronchoscopy. As such, bronchial thermoplasty should be considered a complex interventional bronchoscopy and is intended for the experienced bronchoscopist. Optimal patient management is critical in any such complex and longer duration bronchoscopic procedure. This article discusses the importance of careful patient selection, patient preparation, patient management, procedure duration, postoperative care and follow-up to ensure that bronchial thermoplasty is performed safely. Bronchial thermoplasty is expected to complement asthma maintenance medications by providing long-lasting asthma control and improving asthma-related quality of life of patients with severe asthma. In addition, bronchial thermoplasty has been demonstrated to reduce severe exacerbations (asthma attacks) emergency rooms visits for respiratory symptoms, and time lost from work, school and other daily activities due to asthma.
- Published
- 2010
- Full Text
- View/download PDF
36. [The application of bronchial thermoplasty in the treatment of bronchial asthma].
- Author
-
Sun PP and Tong ZH
- Subjects
- Humans, Asthma surgery, Catheter Ablation
- Published
- 2010
37. Bronchial thermoplasty in asthma.
- Author
-
Rubin AS and Cardoso PF
- Subjects
- Humans, Randomized Controlled Trials as Topic, Asthma surgery, Bronchoscopy methods, Catheter Ablation methods
- Abstract
Currently available treatments for asthma provide satisfactory control of the disease in most cases. However, a significant number of patients do not respond to such treatments (i.e., do not achieve effective symptom relief). One novel approach to treating asthma is bronchial thermoplasty, in which the airway smooth muscle is specifically and directly treated. This procedure delivers radiofrequency energy to the airways in order to reduce smooth muscle-mediated bronchoconstriction. In this article, we present the thermoplasty technique, summarizing the results of the major randomized clinical trials of the procedure, as well as discussing its mechanisms of action and potential adverse effects. We also propose strategies for the future clinical use of this new treatment.
- Published
- 2010
- Full Text
- View/download PDF
38. [Bronchial thermoplasty in asthma: an updated review].
- Author
-
Torrego Fernández A
- Subjects
- Adrenergic alpha-Agonists therapeutic use, Anti-Asthmatic Agents therapeutic use, Beclomethasone therapeutic use, Combined Modality Therapy, Double-Blind Method, Humans, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Treatment Outcome, Asthma surgery, Bronchi surgery, Catheter Ablation
- Published
- 2010
- Full Text
- View/download PDF
39. Bronchial thermoplasty in the treatment of asthma.
- Author
-
Torrego Fernández A
- Subjects
- Animals, Asthma pathology, Bronchi pathology, Bronchoscopes, Bronchoscopy, Dogs, Equipment Design, Follow-Up Studies, Humans, Muscle, Smooth pathology, Muscle, Smooth surgery, Randomized Controlled Trials as Topic statistics & numerical data, Asthma surgery, Bronchi surgery, Catheter Ablation instrumentation, Catheter Ablation methods
- Abstract
Despite the numerous guidelines and treatments available for asthma, the disease remains poorly controlled in some patients, who remain symptomatic, are a considerable burden on the health system, and account for most of the hospitalizations due to asthma. Bronchial thermoplasty is a novel experimental therapeutic option that consists of delivering radiofrequency-generated heat to the airways via a catheter inserted in the bronchial tree through a flexible bronchoscope to reduce smooth muscle quantity and contractility. The first investigations were conducted using an animal model. Subsequently, 2 randomized clinical trials designed to evaluate the safety and efficacy of thermoplasty in patients with moderate to severe asthma with a 1-year follow-up period showed the procedure to be safe, with mostly transient adverse affects and several clinical benefits. Although results from ongoing clinical trials are still awaited, thermoplasty may become an innovative therapeutic approach to asthma., (Copyright 2008 SEPAR. Published by Elsevier Espana. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
40. Bronchial thermoplasty for asthma: a critical review of a new therapy.
- Author
-
Wechsler ME
- Subjects
- Animals, Asthma physiopathology, Bronchi physiopathology, Bronchial Hyperreactivity physiopathology, Equipment Design, Humans, Muscle, Smooth physiopathology, Treatment Outcome, Asthma surgery, Bronchi surgery, Bronchial Hyperreactivity surgery, Catheter Ablation adverse effects, Catheter Ablation instrumentation, Muscle, Smooth surgery
- Abstract
Bronchial thermoplasty (BT) is a novel experimental procedure involving the application of controlled heat from a radiofrequency source to the airway wall as a means to reduce airway smooth muscle in the airway wall. After BT was shown to reduce airway smooth muscle in preclinical studies in dogs, clinical studies in humans revealed that BT resulted in a significant improvement in asthma outcomes including mild asthma exacerbations, asthma symptom-free days, asthma rescue medication use, and airway hyperresponsiveness as measured by methacholine PC(20). A second trial in humans revealed that BT was safe and effective in patients with severe asthma refractory to the current standard of care. While current trials are ongoing, BT holds promise as an exciting novel therapy in the management of patients with asthma.
- Published
- 2008
- Full Text
- View/download PDF
41. Bronchial thermoplasty: a novel approach to asthma treatment.
- Author
-
Shah M
- Subjects
- Animals, Bronchoscopy methods, Humans, Treatment Outcome, Asthma surgery, Bronchi surgery, Catheter Ablation methods
- Published
- 2008
42. [Bronchial thermoplasty--a new therapeutic approach in asthma].
- Author
-
Ulmeanu R
- Subjects
- Evidence-Based Medicine, Humans, Hyperthermia, Induced, Quality of Life, Treatment Outcome, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation
- Published
- 2008
43. [Bronchial thermoplasty: report on the first endoscopic treatment for asthma in Latin America].
- Author
-
Rubin AS and Cardoso PF
- Subjects
- Asthma physiopathology, Catheter Ablation standards, Humans, Latin America, Male, Middle Aged, Asthma surgery, Bronchi surgery, Bronchoscopy methods, Catheter Ablation methods
- Abstract
Bronchial thermoplasty is a new bronchoscopic procedure that delivers radiofrequency energy to the airway and potentially reduces the smooth muscle-mediated bronchoconstriction. We report the case of a 48-year-old man with persistent moderate asthma submitted to bronchial thermoplasty. The treatment increased the forced expiratory volume in one second, increased the number of symptom-free days, reduced the use of relief medications, and improved the Juniper Asthma Quality of Life Scale score. In this patient, bronchial thermoplasty was well tolerated and safe. This was the first bronchial thermoplasty performed in Latin America. At 12 months after the procedure, the results were encouraging in terms of its potential benefits in patients with difficult-to-control asthma.
- Published
- 2008
- Full Text
- View/download PDF
44. New interventions in asthma including bronchial thermoplasty.
- Author
-
Cox G
- Subjects
- Animals, Asthma diagnosis, Bronchoscopy methods, Diagnostic Techniques, Respiratory System, Humans, Phenotype, Anti-Bacterial Agents therapeutic use, Asthma drug therapy, Asthma surgery, Bronchi surgery, Catheter Ablation, Macrolides therapeutic use
- Abstract
Purpose of Review: This article focuses on two novel asthma therapies - antibiotics and a procedure, bronchial thermoplasty. The challenges of identifying which treatment would best help an individual patient can be addressed by use of noninvasive measurements to define their asthma., Recent Findings: Asthma is heterogeneous. Methods can be applied that define different phenotypes. We can now obtain a more detailed description of physiological changes, for example with bronchial provocation, and inflammatory changes, for example with exhaled nitric oxide or sputum cell analysis, in patients with airway symptoms. These measurements help define disease mechanisms and are especially informative when patients do not respond to standard therapy. Furthermore, detailed phenotyping may help identify who is most likely to benefit from newly developed, more specific therapies ranging from antagonists of individual mediators, for example anti-tumor necrosis factor-alpha or anti-immunoglobulin E, to interventions that directly address structural determinants of asthma, for example bronchial thermoplasty., Summary: Asthma treatment is evolving beyond the current cornerstones of bronchodilation, leukotriene antagonism and corticosteroids. This change will be propelled by a more detailed description of individual patients' disease that will enable customization of treatment, and the development of specific interventions that modify disease mechanisms, including airway remodelling.
- Published
- 2008
- Full Text
- View/download PDF
45. Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma.
- Author
-
Pavord ID, Cox G, Thomson NC, Rubin AS, Corris PA, Niven RM, Chung KF, and Laviolette M
- Subjects
- Adult, Bronchi pathology, Catheter Ablation methods, Female, Forced Expiratory Volume, Humans, Hyperthermia, Induced, Male, Middle Aged, Treatment Outcome, Asthma surgery, Bronchi surgery, Catheter Ablation adverse effects, Muscle, Smooth surgery
- Abstract
Rationale: Bronchial thermoplasty (BT) is designed to reduce airway smooth muscle and improve asthma control., Objectives: This study was conducted to determine the safety and efficacy of this procedure in subjects with symptomatic, severe asthma., Methods: Adults who were symptomatic despite treatment with fluticasone or equivalent at more than 750 mug/day, a long-acting beta(2)-agonist, and other medications, which could include 30 mg or less of oral prednisolone/day, were randomized to BT or to a control group. After treatment, subjects entered a 16-week steroid stable phase (Weeks 6-22), a 14-week steroid wean phase (Weeks 22-36), and a 16-week reduced steroid phase (Weeks 36-52)., Measurements and Main Results: BT resulted in a transient worsening of asthma symptoms. Seven hospitalizations for respiratory symptoms occurred in 4 of 15 BT subjects during the treatment period. Five hospitalizations were within 3 days of treatment. Two subjects had segmental collapse involving the most recently treated lobe; one required bronchoscopy and aspiration of a mucus plug. There were no hospitalizations during this period in the 17 control subjects. The rate of hospitalizations was similar in both groups in the post-treatment period. At 22 weeks, BT subjects had significant improvements versus control subjects in rescue medication use (-26.6 +/- 40.1 vs. -1.5 +/- 11.7 puffs/7 d, P < 0.05), prebronchodilator FEV(1)% predicted (14.9 +/- 17.4 vs. -0.94 +/- 22.3%, P = 0.04), and Asthma Control Questionnaire scores (-1.04 +/- 1.03 vs. -0.13 +/- 1.00, P = 0.02). Improvements in rescue medication use and Asthma Control Questionnaire scores remained significantly different from those of controls at 52 weeks., Conclusions: BT is associated with a short-term increase in asthma-related morbidity. However, there is preliminary evidence of long-lasting improvement in asthma control. Clinical trial registered with www.clinicaltrials.gov (NCT 00214539).
- Published
- 2007
- Full Text
- View/download PDF
46. Bronchial thermoplasty.
- Author
-
Macklem PT
- Subjects
- Asthma etiology, Humans, Hyperthermia, Induced, Muscle, Smooth surgery, Asthma surgery, Bronchi surgery, Catheter Ablation, Muscle, Smooth physiopathology
- Published
- 2007
- Full Text
- View/download PDF
47. Bronchial thermoplasty.
- Author
-
Agrawal A
- Subjects
- Asthma physiopathology, Forced Expiratory Volume, Humans, Hyperthermia, Induced, Peak Expiratory Flow Rate, Asthma surgery, Bronchi surgery, Catheter Ablation, Muscle, Smooth surgery
- Published
- 2007
48. Bronchial thermoplasty.
- Author
-
Medford AR
- Subjects
- Animals, Bronchi pathology, Fibrosis etiology, Forced Expiratory Volume, Humans, Hyperthermia, Induced, Asthma surgery, Bronchi surgery, Catheter Ablation adverse effects
- Published
- 2007
49. Asthma control during the year after bronchial thermoplasty.
- Author
-
Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Chaudhuri R, Miller JD, and Laviolette M
- Subjects
- Adrenergic beta-Agonists therapeutic use, Adult, Asthma drug therapy, Asthma physiopathology, Beclomethasone therapeutic use, Bronchial Hyperreactivity therapy, Bronchoscopy, Female, Follow-Up Studies, Forced Expiratory Volume, Glucocorticoids therapeutic use, Humans, Hyperthermia, Induced, Male, Middle Aged, Peak Expiratory Flow Rate, Quality of Life, Asthma surgery, Bronchi surgery, Catheter Ablation adverse effects, Muscle, Smooth surgery
- Abstract
Background: Bronchial thermoplasty is a bronchoscopic procedure to reduce the mass of airway smooth muscle and attenuate bronchoconstriction. We examined the effect of bronchial thermoplasty on the control of moderate or severe persistent asthma., Methods: We randomly assigned 112 subjects who had been treated with inhaled corticosteroids and long-acting beta2-adrenergic agonists (LABA) and in whom asthma control was impaired when the LABA were withdrawn to either bronchial thermoplasty or a control group. The primary outcome was the frequency of mild exacerbations, calculated during three scheduled 2-week periods of abstinence from LABA at 3, 6, and 12 months. Airflow, airway responsiveness, asthma symptoms, the number of symptom-free days, use of rescue medication, and scores on the Asthma Quality of Life Questionnaire (AQLQ) and the Asthma Control Questionnaire (ACQ) were also assessed., Results: The mean rate of mild exacerbations, as compared with baseline, was reduced in the bronchial-thermoplasty group but was unchanged in the control group (change in frequency per subject per week, -0.16+/-0.37 vs. 0.04+/-0.29; P=0.005). At 12 months, there were significantly greater improvements in the bronchial-thermoplasty group than in the control group in the morning peak expiratory flow (39.3+/-48.7 vs. 8.5+/-44.2 liters per minute), scores on the AQLQ (1.3+/-1.0 vs. 0.6+/-1.1) and ACQ (reduction, 1.2+/-1.0 vs. 0.5+/-1.0), the percentage of symptom-free days (40.6+/-39.7 vs. 17.0+/-37.9), and symptom scores (reduction, 1.9+/-2.1 vs. 0.7+/-2.5) while fewer puffs of rescue medication were required. Values for airway responsiveness and forced expiratory volume in 1 second did not differ significantly between the two groups. Adverse events immediately after treatment were more common in the bronchial-thermoplasty group than in the control group but were similar during the period from 6 weeks to 12 months after treatment., Conclusions: Bronchial thermoplasty in subjects with moderate or severe asthma results in an improvement in asthma control. (ClinicalTrials.gov number, NCT00214526 [ClinicalTrials.gov].)., (Copyright 2007 Massachusetts Medical Society.)
- Published
- 2007
- Full Text
- View/download PDF
50. Airway smooth muscle as a target for asthma therapy.
- Author
-
Solway J and Irvin CG
- Subjects
- Bronchoscopy, Humans, Hyperthermia, Induced, Muscle Contraction, Muscle, Smooth physiology, Asthma surgery, Bronchi surgery, Catheter Ablation, Muscle, Smooth surgery
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.